Important thing to watch out is what are the terms of agreement between mylan and novo nordisk? By when (which year) natco can start selling ozempic? Natco still will have to get fda approval
Last time in dec 2015 when there was a out of court settlement by natco with bristol & myers for revlimid natco started selling revlimid in 2022 as the patent was expiring in jan 2026 natco got last 3 years of restricted volume exclusivity which means almost after 6 years natco started selling this drug post there mutual agreement…so we dont want such longer wait period…really hope that this time natco starts selling ozempic in next 2 yrs so that it can compensate revlimids sale post jan 2026
| Subscribe To Our Free Newsletter |
